Opiant Pharmaceuticals, Inc. OPNT
20.65 +20.65
Day range unavailable
52-week range unavailable
Revenue & Expenses
Latest period ending Dec 31, 2021 · select a line to chart its full history
Income statement
| Fiscal year | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 | FY 2017 Jul 31, 2017 |
|---|---|---|---|---|---|
| 47.79M | 29.63M | 40.52M | 13.98M | 18.45M | |
| 47.79M | 29.63M | 40.52M | 13.98M | 18.45M | |
| 5.16M | -2.24M | 10.91M | -21.19M | 7.09M | |
| 3.01M | -1.86M | 11.59M | -21.20M | 6.58M | |
| 0.51 | -0.44 | 2.17 | -7.10 | 2.94 |
Balance sheet
| Fiscal year | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 | FY 2017 Jul 31, 2017 |
|---|---|---|---|---|---|
| 37.85M | 48.25M | 30.98M | 24.61M | 6.87M | |
| 70.43M | 60.61M | 40.28M | 29.39M | 10.81M | |
| 23.59M | 25.12M | 5.86M | 12.53M | 6.47M | |
| 17.08M | 18.98M | 771.60K | 0 | 0 | |
| 46.84M | 35.49M | 34.42M | 16.86M | 4.33M |
Cash flow
| Fiscal year | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 | FY 2017 Jul 31, 2017 |
|---|---|---|---|---|---|
| 1.93M | -2.03M | 4.06M | -522.97K | 5.56M | |
| -15.01M | -50.89K | -302.48K | 0 | 0 | |
| 2.72M | 19.37M | 2.61M | 17.02M | -165.00K | |
| -10.40M | 17.27M | 6.37M | 16.50M | 5.39M |